Detail page

Knowledge Web

Person

Tobias Welte (1959-2024)

Arzt

Name	Tobias Welte
Time	1959-2024 (Date of birth and death)
Place	Frankfurt am Main (Geburtsort) Magdeburg (Wirkungsort) Hannover (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Internist Chefarzt Pneumologe
Variant	T. Welte
Family	Lena Welte (Tochter)
Related	Medizinische Hochschule Hannover Klinik für Pneumologie (Direktor) Medizin (Studienfach)
Further information	Hannover, Med. Hochsch., Diss. 1994; Magdeburg, Univ., Habil.-Schr. 2000; Direktor der Klinik für Pneumologie der Medizinischen Hochschule Hannover. Balzan-Preisträger.
Source	Wikipedia: https://de.wikipedia.org/wiki/Tobias_Welte (Stand: 13.03.2024) LCAuth
Record type	Person
GND-Identifier	133584682
Record ID	133584682
Involved in show all Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie The effect of therapeutic plasma exchange on the inflammatory response in septic shock: a secondary analysis of the EXCHANGE-1 trial Kurzfassung des Updates der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie Seuchen : Fluch der Vergangenheit, Bedrohung der Zukunft Seuchen : Fluch der Vergangenheit, Bedrohung der Zukunft Seuchen : Fluch der Vergangenheit, Bedrohung der Zukunft Amyloid precursor protein as a fibrosis marker in infants with biliary atresia Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysis Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007 Repetitive invasive lung function maneuvers do not accentuate experimental fibrosis in mice Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort The role of vasculature and angiogenesis in respiratory diseases Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRI Herausforderungen und Strategien in der ambulanten und stationären Versorgung von Infektionserkrankungen : Eine interdisziplinäre Perspektive Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD—results from COSYCONET Photon Counting Computed Tomography with the Radiation Dose of a Chest X-Ray: Feasibility and Diagnostic Yield Management erwachsener Patientinnen und Patienten mit Bronchiektasen-Erkrankung : Eine S2k-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP) (AWMF-Registernummer 020-030) Amyloid precursor protein as a fibrosis marker in infants with biliary atresia Association of patients’ knowledge on the disease and its management with indicators of disease severity and individual characteristics in patients with chronic obstructive pulmonary disease (COPD): results from COSYCONET 2 Atrial fibrillation and survival on a medical intensive care unit Infektionstherapie : Antibiotika, Virostatika, Antimykotika, antiparasitäre Wirkstoffe Serum cytokine dysregulation signatures associated with COVID-19 outcomes in high mortality intensive care unit cohorts across pandemic waves and variants The role of vasculature and angiogenesis in respiratory diseases Therapie von Infektionen: Grundlagen: Wahl des Antiinfektivums Challenges in combating sepsis in Germany—Learning from others and the COVID-19 pandemic RSV vaccination strategies for high-risk patients 2023: a collaborative position paper by leading German medical societies and organizations The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19 „Get smart about antibiotics in acute care medicine“ : Fortbildung als wichtige Säule zum rationalen Einsatz von Antiinfektiva Steiniger Weg zur personalisierten Therapie Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP) Point-of-care procalcitonin testing for lower respiratory tract infection in pulmonary outpatient care has limited value Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia Risiko und Häufigkeit von Long-COVID The Exception Proves the Rule: First Case of Tuberous Sclerosis-Related Pulmonary Lymphangioleiomyomatosis (LAM) in a Male Adolescent Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis Etablierung von Intensivnachsorge-Ambulanzen – mehr Fragen als Antworten Eine Einführung in die pulmonale Hämorrhagie aus Sicht der Pneumologie Comment on : Intrapulmonary shunt and alveolar dead space in a cohort of patients with acute COVID-19 pneumonitis and early recovery Die Tabakabhängigkeit : eine Analyse des Kenntnis- und Erfahrungsstandes in Gesundheitsberufen sowie Evaluation von Ansätzen zur Primär- und Sekundärprävention Fibrosis-related gene profiling in liver biopsies of pizz α1-antitrypsin children with different clinical courses Infektionstherapie : Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe Infektionstherapie : Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe Novel Insight into Pulmonary Fibrosis and Long COVID Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians Update Intensivmedizin 2023 : IntensivUpdate 2023 Cardiovascular predictors of mortality and exacerbations in patients with COPD Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? Plasma markers of COVID-19 severity: a pilot study Pleural CD14 + monocytes/macrophages of healthy adolescents show a high expression of metallothionein family genes Inflammation and vascular remodeling in COVID-19 hearts Antibiotic Stewardship in der Pneumologie

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Tobias Welte (1959-2024)

Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie

The effect of therapeutic plasma exchange on the inflammatory response in septic shock: a secondary analysis of the EXCHANGE-1 trial

Kurzfassung des Updates der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie

Seuchen : Fluch der Vergangenheit, Bedrohung der Zukunft

Seuchen : Fluch der Vergangenheit, Bedrohung der Zukunft

Seuchen : Fluch der Vergangenheit, Bedrohung der Zukunft

Amyloid precursor protein as a fibrosis marker in infants with biliary atresia

Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysis

Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007

Repetitive invasive lung function maneuvers do not accentuate experimental fibrosis in mice

Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis

Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort

The role of vasculature and angiogenesis in respiratory diseases

Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy

Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation

Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRI

Herausforderungen und Strategien in der ambulanten und stationären Versorgung von Infektionserkrankungen : Eine interdisziplinäre Perspektive

Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD—results from COSYCONET

Photon Counting Computed Tomography with the Radiation Dose of a Chest X-Ray: Feasibility and Diagnostic Yield

Management erwachsener Patientinnen und Patienten mit Bronchiektasen-Erkrankung : Eine S2k-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP) (AWMF-Registernummer 020-030)

Amyloid precursor protein as a fibrosis marker in infants with biliary atresia

Association of patients’ knowledge on the disease and its management with indicators of disease severity and individual characteristics in patients with chronic obstructive pulmonary disease (COPD): results from COSYCONET 2

Atrial fibrillation and survival on a medical intensive care unit

Infektionstherapie : Antibiotika, Virostatika, Antimykotika, antiparasitäre Wirkstoffe

Serum cytokine dysregulation signatures associated with COVID-19 outcomes in high mortality intensive care unit cohorts across pandemic waves and variants

The role of vasculature and angiogenesis in respiratory diseases

Therapie von Infektionen: Grundlagen: Wahl des Antiinfektivums

Challenges in combating sepsis in Germany—Learning from others and the COVID-19 pandemic

RSV vaccination strategies for high-risk patients 2023: a collaborative position paper by leading German medical societies and organizations

The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial

Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19

„Get smart about antibiotics in acute care medicine“ : Fortbildung als wichtige Säule zum rationalen Einsatz von Antiinfektiva

Steiniger Weg zur personalisierten Therapie

Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)

Point-of-care procalcitonin testing for lower respiratory tract infection in pulmonary outpatient care has limited value

Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation

Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

Risiko und Häufigkeit von Long-COVID

The Exception Proves the Rule: First Case of Tuberous Sclerosis-Related Pulmonary Lymphangioleiomyomatosis (LAM) in a Male Adolescent

Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis

Etablierung von Intensivnachsorge-Ambulanzen – mehr Fragen als Antworten

Eine Einführung in die pulmonale Hämorrhagie aus Sicht der Pneumologie

Comment on : Intrapulmonary shunt and alveolar dead space in a cohort of patients with acute COVID-19 pneumonitis and early recovery

Die Tabakabhängigkeit : eine Analyse des Kenntnis- und Erfahrungsstandes in Gesundheitsberufen sowie Evaluation von Ansätzen zur Primär- und Sekundärprävention

Fibrosis-related gene profiling in liver biopsies of pizz α1-antitrypsin children with different clinical courses

Infektionstherapie : Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe

Infektionstherapie : Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe

Novel Insight into Pulmonary Fibrosis and Long COVID

Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia

Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians

Update Intensivmedizin 2023 : IntensivUpdate 2023

Cardiovascular predictors of mortality and exacerbations in patients with COPD

Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?

Plasma markers of COVID-19 severity: a pilot study

Pleural CD14 + monocytes/macrophages of healthy adolescents show a high expression of metallothionein family genes

Inflammation and vascular remodeling in COVID-19 hearts

Antibiotic Stewardship in der Pneumologie